BioLineRx (BLRX) Property, Plant & Equipment (Net) (2011 - 2026)
BioLineRx's Property, Plant & Equipment (Net) was $130,000 in the quarter ended Jun 30, 2026, down 34.0% from $197,000 a year earlier and down 11.0% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Property, Plant & Equipment (Net) (2011 - 2026) Analysis & Trends
As of Dec 31, 2025, Property, Plant & Equipment (Net) at BioLineRx came in at $160,000, down 58.5% from the prior year.
- Property, Plant & Equipment (Net) has now declined for ten consecutive years, with a five-year compound annual growth rate of -34.6% (years ended Dec 2020 to Dec 2025).
- In earlier years, Property, Plant & Equipment (Net) was $386,000 in the year ended Dec 31, 2024 (-18.4%), $473,000 in the year ended Dec 31, 2023 (-34.8%), $726,000 in the year ended Dec 31, 2022 (-23.7%) and $952,000 in the year ended Dec 31, 2021 (-29.0%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Property, Plant & Equipment (Net) in data going back to the quarter ended Sep 30, 2011.
- Compared with a year earlier, Property, Plant & Equipment (Net) has declined for 40 straight quarters, with an average decline of 40.0% over the last eight quarters.
- Over the past five years, the year-over-year decline in Property, Plant & Equipment (Net) ranged from 18.4% (the quarter ended Dec 31, 2024) to 58.5% (the quarter ended Dec 31, 2025).
- Per Business Quant data, BLRX's Property, Plant & Equipment (Net) in the three quarters before the quarter ended Jun 30, 2026 was $146,000 (quarter ended Mar 31, 2026), $160,000 (quarter ended Dec 31, 2025) and $168,000 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 29.29 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 23.58 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 5.80 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 25.74 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 10.69 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 13.62 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 8.55 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 5.83 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 19.03 Bn |
| 10 | BioLineRx | 6.06 Bn | 6.06 Bn | 235,000.00 | 130,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 130,000.00 |
| Mar 31, 2026 | 146,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Sep 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 197,000.00 |
| Mar 31, 2025 | 299,000.00 |
| Dec 31, 2024 | 386,000.00 |
| Sep 30, 2024 | 249,000.00 |
| Jun 30, 2024 | 344,000.00 |
| Mar 31, 2024 | 411,000.00 |
| Dec 31, 2023 | 473,000.00 |
| Sep 30, 2023 | 561,000.00 |
| Jun 30, 2023 | 648,000.00 |
| Mar 31, 2023 | 666,000.00 |
| Dec 31, 2022 | 726,000.00 |
| Sep 30, 2022 | 726,000.00 |
| Jun 30, 2022 | 810,000.00 |
| Mar 31, 2022 | 855,000.00 |
| Dec 31, 2021 | 952,000.00 |
| Sep 30, 2021 | 1.02 Mn |
API Access
BioLineRx Property, Plant & Equipment (Net) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "property-plant-and-equipment-net", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();